|
Contents
|
|
|
|
|
|
|
|
Noteworty
Overviews
|
|
|
|
General
Overviews
|
|
|
|
|
Adamson DC, Rasheed BA, McLendon RE, Bigner DD.
Central nervous system.
Cancer
Biomark. 2011 Jan 1;9(1):193-210.
.JPG)
Abstract |
.gif)
Related articles
|
|
|
Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD.
Glioblastoma
multiforme: a review of where we have been and where we are going.
Expert
Opin Investig Drugs. 2009 Aug;18(8):1061-83.
Abstract |
Related articles
|
|
|
Ahluwalia
MS.
American Society of
Clinical Oncology 2011 CNS tumors update.
Expert Rev Anticancer
Ther. 2011 Oct;11(10):1495-7.
Abstract |
.png)
Reprint |
Related articles
|
|
|
Bartek
J Jr, Ng K, Bartek J, Fischer W, Carter B, Chen CC.
Key
concepts in glioblastoma therapy.
J
Neurol Neurosurg Psychiatry. 2012 Mar 6. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Brandes
AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C
Glioblastoma in adults.
Crit Rev Oncol Hematol. 2008 Apr 3; [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
|
Cimini
A, Ippoliti R.
Innovative Therapies against Human Glioblastoma Multiforme.
ISRN Oncol. 2011;2011:787490. Epub 2011 Jul 24.
Abstract |
Reprint |
Related articles
|
|
|
Clarke J, Butowski N, Chang S.
Recent advances in therapy for glioblastoma.
Arch Neurol. 2010
Mar;67(3):279-83.
Abstract |
Reprint |
Related articles
|
|
|
Emdad L, Dent P, Sarkar D, Fisher PB.
Future approaches for the therapy of malignant glioma: targeting genes
mediating invasion.
Future Oncol.
2012 Apr;8(4):343-6.
Abstract |
Reprint |
Related articles
|
|
|
Ghose A, Lim G, Husain S.
Treatment for glioblastoma multiforme: current guidelines and Canadian
practice.
Curr Oncol.
2010 Nov;17(6):52-8.
Abstract
|
Reprint
|
Related articles
|
|
|
Holdhoff M, Grossman SA.
Controversies in the adjuvant therapy of high-grade gliomas.
Oncologist.
2011;16(3):351-8. Epub 2011 Feb 21.
Abstract |
Reprint |
Related articles
|
|
|
Khasraw
M, Lassman AB.
Advances in the treatment of malignant gliomas.
Curr Oncol Rep. 2010 Jan 5;12(1):26-33
Abstract |
Reprint
| Related
articles
|
|
|
Ohka F, Natsume A, Wakabayashi T.
Current trends in targeted therapies for glioblastoma multiforme.
Neurol Res Int.
2012;2012:878425. Epub 2012 Mar 5.
Abstract |
Reprint |
Related articles
|
|
|
Perry J, Okamoto M, Guiou M, Shirai K, Errett A, Chakravarti A.
Novel therapies in glioblastoma.
Neurol Res Int.
2012;2012:428565. Epub 2012 Feb 28.
Abstract |
Reprint |
Related articles
|
|
|
Reardon DA, Rich
JN,
Friedman HS, Bigner DD.
Recent Advances in the Treatment of Malignant Astrocytoma.
J
Clin Oncol. 2006 Mar 10;24(8):1253-65.
Abstract |
Reprint |
Related articles
|
|
|
Reardon
DA,
Wen PY.
Therapeutic Advances in the Treatment
of Glioblastoma: Rationale and Potential Role of Targeted Agents.
The Oncologist, Vol. 11, No. 2, 152-164, February 2006
Abstract
|
Reprint
|
Related
articles
|
|
|
Mut
M, Schiff D.
Unmet
needs in the treatment of glioblastoma.
Expert
Rev Anticancer Ther. 2009 May;9(5):545-51.
Abstract |
Reprint |
Related articles
|
|
|
Nishikawa
R.
Standard therapy for glioblastoma--a review of where we are.
Neurol Med Chir (Tokyo). 2010;50(9):713-9. Release Date: September 25, 2010
Abstract |
Reprint |
Related articles
|
|
|
Scoccianti
S, Magrini SM, Ricardi U, Detti B, Buglione M, Sotti G, Krengli M, Maluta S,
Parisi S, Bertoni F, Mantovani C, Tombolini V, De Renzis C, Lioce M,
Fatigante L, Fusco V, Muto P, Berti F, Rubino G, Cipressi S, Fariselli L,
Lupattelli M, Santoni R, Pirtoli L, Biti G
Patterns
of care and survival in a retrospective analysis of 1059 patients with
glioblastoma multiforme treated between 2002 and 2007: a multicenter study
by the Central Nervous System Study Group of Airo (italian Association of
Radiation Oncology)
Neurosurgery.
2010 Aug;67(2):446-58
Abstract |
Reprint
|
Related
articles
|
|
|
Stupp R, Hegi ME, van den Bent MJ,
Mason WP, Weller M, Mirimanoff RO, Cairncross JG;
European Organisation for Research and Treatment of Cancer Brain Tumor and
Radiotherapy Groups;
National Cancer Institute of Canada Clinical Trials Group.
Changing
Paradigms—An Update on the Multidisciplinary Management of Malignant
Glioma.
Oncologist. 2006 Feb;11(2):165-80.
Abstract
|
Reprint
|
Related
articles
|
|
|
Weller M.
Novel
diagnostic and therapeutic approaches to malignant glioma.
Swiss Med Wkly. 2011
May 24;141:w13210.
Abstract |
Reprint |
Related articles
|
|
|
Wong
ET, Yamaguchi NH.
Treatment advances for
glioblastoma.
Expert Rev Neurother. 2011 Oct;11(10):1343-5.
Abstract |
Reprint |
Related articles
|
|
|
Yabroff KR, Harlan L, Zeruto C, Abrams J, Mann B.
Patterns
of care and survival for patients with glioblastoma multiforme diagnosed
during 2006.
Neuro Oncol. 2012
Mar;14(3):351-9. Epub 2012 Jan 12.
Abstract |
Related articles
|
|
|
ESMO clin. recommend.
|
|
|
|
|
Stupp
R,
Tonn
J-C.,
Brada
M, Pentheroudakis G and On
behalf of the ESMO Guidelines Working Group
High-grade malignant glioma: ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up
Ann Oncol
(2010) 21 (suppl
5): v190-v193, June 2010
Abstract |
Reprint |
Related
articles
|
|
|
Stupp R, Roila F; ESMO Guidelines Working Group.
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and
follow-up.
Ann
Oncol. 2009 May;20 Suppl 4:126-8.
Abstract |
Reprint |
Related articles
|
|
|
Stupp R, Hottinger AF, van den Bent MJ, Dietrich PY, Brandes AA.
Frequently
asked questions in the medical management of high-grade glioma: a short
guide with practical answers.
Ann
Oncol. 2008 Sep;19 Suppl 7:vii209-16
Abstract |
Reprint |
Related articles
|
|
|
Stupp R, Hottinger AF.
Management
of malignant glioma--quo vadis?
Onkologie.
2008 Jun;31(6):300-2. Epub 2008 May 27.
Abstract |
Reprint |
Related articles
|
|
|
Stupp R, Roila F; ESMO Guidelines Working Group.
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and
follow-up.
Ann
Oncol. 2008 May;19 Suppl 2:ii83-5.
Abstract |
Related articles
|
|
|
ESMO Guidelines Working Group, Stupp R.
Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and
follow-up.
Ann
Oncol. 2007 Apr;18 Suppl 2:ii69-70. Erratum in: Ann Oncol. 2008 May;19(5):1027-9.
Abstract |
Reprint
Erratum
|
Related articles
|
|
|
Response Criteria
|
|
|
|
|
Brandes AA, Franceschi E.
New
Agents and New End Points for Recurrent Gliomas.
J
Clin Oncol. 2011 Jan 31. [Epub ahead of print]
Abstract |
Reprint |
Related articles
|
|
Cook B, Dvorak T.
Radiation Oncology/CNS/High grade glioma/Overview
Wikibooks. 2008
Abstract
|
|
|
Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ,
Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF.
Recursive partitioning analysis of prognostic factors in three Radiation
Therapy Oncology Group malignant glioma trials.
J Natl
Cancer Inst. 1993 May 5;85(9):704-10.
Abstract |
Related articles
|
|
|
Li
J, Wang M, Won M, Shaw EG, Coughlin C, Curran WJ Jr, Mehta MP.
Validation and Simplification of the Radiation Therapy Oncology Group
Recursive Partitioning Analysis Classification for Glioblastoma.
Int J Radiat Oncol Biol Phys. 2010 Oct 1;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG.
Response criteria for phase II studies of supratentorial malignant glioma.
J
Clin Oncol. 1990 Jul;8(7):1277-80.
Abstract |
Reprint |
Related articles
|
|
|
Quant
EC, Wen PY.
Response Assessment in Neuro-Oncology.
Curr Oncol Rep. 2010 Nov 19;. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Pediatric
Patients
|
|
|
|
|
Ononiwu C, Mehta V, Bettegowda C, Jallo G.
Pediatric
spinal glioblastoma multiforme: current treatment strategies and possible
predictors of survival.
Childs
Nerv Syst. 2012 Feb 4. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Noteworthy
Lab Investigations
|
|
|
|
|
Charles N, Holland EC.
Brain tumor treatment increases the number of cancer stem-like cells
Expert Rev Neurother. 2009 Oct;9(10):1447-9
Abstract |
Reprint
| Related
articles
|
|
|
First-diagnosis
Tumors
|
|
|
|
|
Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC.
Stereotactic
radiosurgery eligibility and selection bias in the treatment of glioblastoma
multiforme.
J Neurooncol.
2010 Jun;98(2):253-63. Epub 2010 Apr 10.
Abstract |
Reprint |
Related articles
|
|
|
Holdhoff M, Grossman SA.
Controversies in the adjuvant therapy of high-grade gliomas.
Oncologist.
2011;16(3):351-8. Epub 2011 Feb 21.
Abstract |
Reprint |
Related articles
|
|
|
Olson JJ, Fadul CE, Brat DJ, Mukundan S, Ryken TC.
Management
of newly diagnosed glioblastoma: guidelines development, value and
application.
J
Neurooncol. 2009 May;93(1):1-23. Epub 2009 May 9.
Abstract |
Reprint |
Related articles
|
|
|
Olson JJ, Ryken T.
Guidelines
for the treatment of newly diagnosed glioblastoma: introduction.
J
Neurooncol. 2008 Sep;89(3):255-8. Epub 2008 May 23.
Abstract |
Reprint |
Related articles
|
|
|
Recurrent
Tumors
|
|
|
|
|
Franceschi
E, Tosoni A, Bartolini S, Mazzocchi V, Fioravanti A, Brandes AA.
Treatment
options for recurrent glioblastoma: pitfalls and future trends.
Expert
Rev Anticancer Ther. 2009 May;9(5):613-9.
Abstract |
.png)
Full Text |
Related articles
|
|
|
Methodology
|
|
|
|
|
Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy
TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey
L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Hibberts J, Peterson PM, Prados
MD.
Progression-free survival: An important end point in evaluating therapy
for recurrent high-grade gliomas.
Neuro Oncol. 2008 Mar 4; [Epub ahead of print]
Abstract |
Reprint
| Related
articles | Cited
by
|
|
|
Complications
|
|
|
|
|
|
|
|
